|
Originally published In Press as doi:10.1074/jbc.M110316200 on November 5, 2001
J. Biol. Chem., Vol. 277, Issue 2, 1433-1442, January 11, 2002
Binding of the Natural Killer Cell Inhibitory
Receptor Ly49A to Its Major Histocompatibility Complex Class I
Ligand
CRUCIAL CONTACTS INCLUDE BOTH H-2Dd AND
2-MICROGLOBULIN*
Jian
Wang ,
Mary C.
Whitman ,
Kannan
Natarajan ,
José
Tormo§,
Roy A.
Mariuzza¶, and
David H.
Margulies
From the Molecular Biology Section, Laboratory of
Immunology, NIAID, National Institutes of Health, Bethesda, Maryland
20892-1892, § Campus de la Universidad Autonoma de Madrid,
28049 Madrid, Spain, and ¶ Center for Advanced Research in
Biotechnology, University of Maryland Biotechnology Institute,
Rockville, Maryland 20850
Ly49A, an inhibitory C-type lectin-like mouse
natural killer cell receptor, functions through interaction with the
major histocompatibility complex class I molecule,
H-2Dd. The x-ray crystal structure of the
Ly49A·H-2Dd complex revealed that homodimeric
Ly49A interacts at two distinct sites of H-2Dd: Site 1, spanning one side of the 1 and 2 helices, and Site 2, involving
the 1, 2, 3, and 2m domains. Mutants of Ly49A, H-2Dd, and 2-microglobulin at intermolecular
contacts and the Ly49A dimer interface were examined for binding
affinity and kinetics. Although mutations at Site 1 had little affect,
several at Site 2 and at the dimer interface hampered the
Ly49A·H-2Dd interaction, with no effect on gross
structure or T cell receptor interaction. The region surrounding the
most critical residues (in H-2Dd,
Asp122; in Ly49A, Asp229,
Ser236, Thr238, Arg239, and
Asp241; and in 2-microglobulin,
Gln29 and Lys58) of the
Ly49A·H-2Dd interface at Site 2 includes a network of
water molecules, suggesting a molecular basis for allelic specificity
in natural killer cell recognition.
*
This work was supported in part by National Institutes of
Health Grants AI47900 and GM52801 (to R. A. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This paper is dedicated to the memory of José Tormo, colleague
and friend.
To whom correspondence should be addressed: Molecular Biology
Section, LI/NIAID, Bldg. 10, Rm. 11N311, National Institutes of Health,
Bethesda, MD 20892-1892. Tel.: 301-496-6429; Fax: 301-496-0222; E-mail:
dhm@nih.gov.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Deng, S. Cho, E. L. Malchiodi, M. C. Kerzic, J. Dam, and R. A. Mariuzza
Molecular Architecture of the Major Histocompatibility Complex Class I-binding Site of Ly49 Natural Killer Cell Receptors
J. Biol. Chem.,
June 13, 2008;
283(24):
16840 - 16849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kaiser, J. C. Pizarro, J. Kerns, and R. K. Strong
Structural basis for NKG2A/CD94 recognition of HLA-E
PNAS,
May 6, 2008;
105(18):
6696 - 6701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Lavender, H. H. Chau, and K. P. Kane
Distinctive Interactions at Multiple Site 2 Subsites by Allele-Specific Rat and Mouse Ly49 Determine Functional Binding and Class I MHC Specificity
J. Immunol.,
November 15, 2007;
179(10):
6856 - 6866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Benoit and R. Tan
Xenogeneic beta2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells
J. Immunol.,
September 15, 2007;
179(6):
3588 - 3595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Adams, Z. S. Juo, R. T. Venook, M. J. Boulanger, H. Arase, L. L. Lanier, and K. C. Garcia
Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors
PNAS,
June 12, 2007;
104(24):
10128 - 10133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Back, A. Chalifour, L. Scarpellino, and W. Held
Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact
PNAS,
March 6, 2007;
104(10):
3978 - 3983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Scarpellino, F. Oeschger, P. Guillaume, J. D. Coudert, F. Levy, G. Leclercq, and W. Held
Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis
J. Immunol.,
February 1, 2007;
178(3):
1277 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Lavender and K. P. Kane
Cross-Species Dependence of Ly49 Recognition on the Supertype Defining B-Pocket of a Class I MHC Molecule
J. Immunol.,
December 15, 2006;
177(12):
8578 - 8586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Benoit, J. Shannon, J. W. Chamberlain, and R. G. Miller
Influence of Xenogeneic {beta}2-Microglobulin on Functional Recognition of H-2Kb by the NK Cell Inhibitory Receptor Ly49C
J. Immunol.,
September 15, 2005;
175(6):
3542 - 3553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Smith, T. Patterson, and M. E. Pauza
Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes
J. Immunol.,
April 1, 2005;
174(7):
3897 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mitsuki, N. Matsumoto, and K. Yamamoto
A species-specific determinant on {beta}2-microglobulin required for Ly49A recognition of its MHC class I ligand
Int. Immunol.,
February 1, 2004;
16(2):
197 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Ma, E. T. Silver, B. Hazes, and K. P. Kane
Reciprocal Transfer of Class I MHC Allele Specificity between Activating Ly-49P and Ly-49W Receptors by Exchange of {beta}4-{beta}5 Loop Residues
J. Immunol.,
November 15, 2003;
171(10):
5337 - 5344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Mason, J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo
Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I
J. Immunol.,
October 15, 2003;
171(8):
4235 - 4242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McShane, M. M. Mullen, K. M. Haan, T. S. Jardetzky, and R. Longnecker
Mutational Analysis of the HLA Class II Interaction with Epstein-Barr Virus Glycoprotein 42
J. Virol.,
July 1, 2003;
77(13):
7655 - 7662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Hill, T. Kasliwal, E. Schwarz, A. M. Hebert, T. Chen, E. Gubina, L. Zhang, and S. Kozlowski
A Dominant Negative Mutant beta 2-Microglobulin Blocks the Extracellular Folding of a Major Histocompatibility Complex Class I Heavy Chain
J. Biol. Chem.,
February 14, 2003;
278(8):
5630 - 5638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Silver, K. J. Lavender, D.-E. Gong, B. Hazes, and K. P. Kane
Allelic Variation in the Ectodomain of the Inhibitory Ly-49G2 Receptor Alters Its Specificity for Allogeneic and Xenogeneic Ligands
J. Immunol.,
November 1, 2002;
169(9):
4752 - 4760.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|